CHRS icon

Coherus Oncology, Inc. Common Stock
CHRS

Overview Fund Activity

110 hedge funds and large institutions have $40.4M invested in Coherus Oncology, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
-6
Holders Change %
-5.17%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
34
Reduced
33
Closed
20
Calls
$128K
Puts
$40K
Net Calls
+$88K
Net Calls Change
-$18K

Top Buyers

1
PAM
Panagora Asset Management
Massachusetts
$581K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$248K
3
UBS Group
UBS Group
Switzerland
$420K
4
LPL Financial
LPL Financial
California
$148K
5
Citadel Advisors
Citadel Advisors
Florida
$98K

Top Sellers

1
RCMNY
Rubric Capital Management (New York)
New York
$635K
2
Millennium Management
Millennium Management
New York
$1.01M
3
Los Angeles Capital Management
Los Angeles Capital Management
California
$284K
4
Vanguard Group
Vanguard Group
Pennsylvania
$7.73M
5
SCM
Stonepine Capital Management
Oregon
$45.9K
Name Holding Trade Value Shares
Change 		Shares
Change %
PNC Financial Services Group
126
PNC Financial Services Group
Pennsylvania
– -$264 -327 Closed
CPG
127
Cornerstone Planning Group
New Jersey
– -$54 -49 Closed
FFA
128
Farther Finance Advisors
California
– -$38 -47 Closed
2 3 4 5
6